Patent Insights
“The CAFC found no error in the jury instructions, which defined the ordinary observer as ‘a person who buys and uses the product at issue’ and ‘correctly instructed [the jury] that the question is how the ordinary observer would view the article as a whole.’” The U.S. Court of Appeals for the Federal Circuit (CAFC) …
March 19, 2020 Information Notice No. 5/2020 relating to the ‘Remedies Available in Case of Failure to Meet a Time Limit and Extension of Time Limits in Case of Closure’ is now available on the WIPO website. Download the full information notice (HAGUE/2020/5) Sourcing Info
We live in interesting times. No corner of professional or personal life seems untouched in at least some way by the latest coronavirus (named SARS-CoV-2) and the disease it causes (named “coronavirus disease 2019” abbreviated COVID-19). Governments all around the world are either demanding or suggesting that people quarantine themselves or engage in social distancing. …
“Were the statute ambiguous, we would alternatively resolve this matter in the same way. Specifically, we would find that no deference is due to the POP opinion in Proppant and that the most reasonable reading of § 315(c) is the one we adopt in our majority opinion.” Chief Judge Prost, Federal Circuit. In Facebook v. …
Facebook v. Windy City: CAFC Strikes Down PTAB’s Approach to Joinder in IPRs Read More »
“The offer of a royalty-free license to any third party working on diagnostics tests directed to COVID-19 is a generous response not only to bioMerieux, not only to all the biopharma companies working on COVID-19, but to everyone, period. We all have an interest in this issue, as the world around us shutters.” Some people …
Twisting Facts to Capitalize on COVID-19 Tragedy: Fortress v. bioMerieux Read More »
Case Number Action Plaintiff Defendant Patent 3:20-cv-02542 Filed JAMES J MACORGOLDFINCH DESIGN STUDIO, LLC HID Global Corp.COLLECTOR`S UNIVERSE, INC. dba PROFESSIONAL COINN GRADING SERVICES 8376133 1:20-cv-00347 Filed Gilead SciencesAstellas Pharma Gland Pharma, Ltd. 8106183RE473018524883 2:20-cv-02608 Filed Celgene Mylan 10555939 2:20-cv-02614 Filed Celgene Teva Pharmaceutical 10555939 2:20-cv-02299 Filed JBF Interlude 2009 Ltd – Israel Quibi Holdings, …
Patent Filings Roundup: Uptick Despite COVID-19, Theranos Patents Reemerge Read More »
Current Events Network Issues Affecting Inbound and Outbound Phone Calls The USPTO is currently experiencing network issues affecting inbound and outbound calls. Calls may be disconnected from the phone system. The USPTO technical teams are working to resolve the issue. Open Data Patent Office Action Data Updates Unavailable Due to internal maintenance on Patent content systems …
March 6, 2020 On March 6, 2020, the Government of Mexico deposited its instrument of accession to the Geneva Act (1999) of the Hague Agreement with WIPO’s Director General Francis Gurry. Mexico is the first Spanish-speaking country in Latin America to join the Hague System and becomes the 64th member of the 1999 Act and …
February 28, 2020 Information notice No. 3/2020 relating to the Changes in the amounts of the individual designation fee and the maximum duration of protection: Japan is now available on the WIPO website. Read full information notice (HAGUE/2020/3) Sourcing Info
January 30, 2020 The Agreement on the Withdrawal of the United Kingdom (UK) from the European Union (EU) provides for a transition period starting on February 1, 2020, the date on which the UK will leave the EU, and ending on December 31, 2020. This Agreement provides for continued protection in the UK for industrial …
Brexit Agreement: Implications for Hague System Users Read More »
